Posted on July 29, 2021GMO
By Kenny Stancil
In a move that environmental groups celebrated as a “historic victory” following years of campaigning to remove Roundup and similar weedkillers from store shelves, Bayer on Thursday announced that it will halt the sale of glyphosate-based herbicides to consumers in the U.S. lawn and garden market by 2023.
“Bayer’s decision to end U.S. residential sale[s] of Roundup is a historic victory for public health and the environment,” Andrew Kimbrell, executive director of the Center for Food Safety (CFS), said in a statement.
“As agricultural, large-scale use of this toxic pesticide continues,” he added, “our farmworkers remain at risk. It’s time for EPA to act and ban glyphosate for all uses.”
While calling the announcement “an important victory to protect the health of Americans,” Kendra Klein, senior scientist at Friends of the Earth, stressed that “action on this toxic weedkiller can’t wait until 2023. Major home and garden retailers like Home Depot and Lowe’s must lead the industry by ending the sales of Roundup immediately.”
The key ingredient found in Roundup, the world’s most widely used herbicide, is glyphosate. Described by the World Health Organization as “probably carcinogenic,” glyphosate poses threats to human health and to pollinators such as bumblebees and monarch butterflies.
Bayer stated that it will switch Roundup and other glyphosate-based weedkillers to formulas that “rely on alternative active ingredients” in order to “manage litigation risk and not because of any safety concerns.”
Thursday’s decision came in response to several legal battles that Bayer, a German pharmaceutical and biotech corporation, inherited when it acquired Monsanto, a U.S. agrochemical giant and creator of Roundup, in 2018.
Last year, Bayer announced multiple massive settlements totaling more than $11 billion to compensate individuals harmed by two Monsanto herbicides.
In one case, the company agreed to pay $10.9 billion to about 125,000 people who alleged the use of Roundup was to blame for their cancer diagnoses.
By upholding the previous judgment against Monsanto, Kimbrell said at the time, the court “unanimously rejected Bayer’s argument that Mr. Hardeman and thousands of others harmed by their products are prohibited by federal law from suing to redress their injuries.”
In a separate settlement last year, Bayer agreed to pay $400 million to thousands of farmers whose crops had been damaged as a result of the widespread drift of Monsanto’s dicamba herbicide. That agreement was preceded by two lawsuits that, according to CFS, “likely provided impetus for Bayer to settle.”
In California, jury trials over Monsanto’s Roundup and dicamba products continue to be held.
Meanwhile, CFS is also currently representing a coalition of farmworkers and environmentalists in a lawsuit that seeks to reverse the Environmental Protection Agency’s approval of glyphosate, which was reviewed and registered in January 2020 by Trump administration officials.
While President Joe Biden’s EPA admitted in May that the Trump-era assessment of glyphosate was flawed and requires a do-over, the agency failed to provide a deadline for a new decision and argued that Roundup should remain on U.S. shelves in the meantime.
Given that Bayer’s decision to stop selling glyphosate-based herbicides by 2023 only applies to consumers in the U.S. lawn and garden market, Klein emphasized that “the battle against this toxic chemical is far from over.”
“Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops,” she added. “Retailers and regulators must act now to ban this cancer-linked weedkiller.”
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Source: Common Dreams
Kenny Stancil is a staff writer for Common Dreams.
Thanks to: https://www.naturalblaze.com